Ceramide-1-phosphate inhibits cigarette smoke-induced airway inflammation

European Respiratory Journal

Volumn 45, Issue 6, 2015, Pages 1669-1680

  Baudiß, Kristin ^a   Ayata, Cemil Korcan ^a   Lazar, Zsofia ^a   Cicko, Sanja ^a   Beckert, Jessica ^a   Meyer, Anja ^a   Zech, Andreas ^a   Vieira, Rodolfo Paula ^a   Bittman, Robert ^b   Gómez Muñoz, Antonio ^c   Merfort, Irmgard ^d   Idzko, Marco ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE 1 PHOSPHATE; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; SPHINGOMYELIN PHOSPHODIESTERASE; CERAMIDE; CERAMIDE 1-PHOSPHATE; CYTOKINE; MESSENGER RNA; SMOKE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL CULTURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA BINDING; EMPHYSEMA; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUOROMETRY; FORCED EXPIRATORY VOLUME; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INTRAPULMONARY DRUG ADMINISTRATION; LUNG ALVEOLUS EPITHELIUM CELL; LUNG LAVAGE; MOUSE; NEUTROPHIL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; SMOKING; ADULT; AGED; ANIMAL; BRONCHOALVEOLAR LAVAGE FLUID; C57BL MOUSE; CROSS-SECTIONAL STUDY; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; EPITHELIUM CELL; FEMALE; GENETICS; IMMUNOLOGY; INFLAMMATION; LUNG; LUNG EMPHYSEMA; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; RESPIRATORY TRACT MUCOSA; SMOKE; TOBACCO;

ADULT; AGED; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; CERAMIDES; CROSS-SECTIONAL STUDIES; CYTOKINES; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FEMALE; HUMANS; INFLAMMATION; LUNG; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; NEUTROPHILS; NF-KAPPA B; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; RESPIRATORY MUCOSA; RNA, MESSENGER; SMOKE; SPHINGOMYELIN PHOSPHODIESTERASE; TOBACCO;

EID: 84929341177     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00080014     Document Type: Article

References (37)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2014. www.goldcopd.com/uploads/users/files/GOLD-Report-2014-Oct30.pdf Date last updated: 2014. Date last accessed: January 8, 2014.
2. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003; 22: 672-688.
3. McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011; 365: 1567-1575.
4. Mukaida N, Mahe Y, Matsushima K. Cooperative interaction of nuclear factor-kappa B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J Biol Chem 1990; 265: 21128-21133.
5. Petrache I, Natarajan V, Zhen L, et al. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med 2005; 11: 491-498.
6. Becker KA, Riethmuller J, Luth A, et al. Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis. Am J Respir Cell Mol Biol 2010; 42: 716-724.
7. Schweitzer KS, Hatoum H, Brown MB, et al. Mechanisms of lung endothelial barrier disruption induced by cigarette smoke: role of oxidative stress and ceramides. Am J Physiol Lung Cell Mol Physiol 2011; 301: L836-L846.
8. Niwa S, Urtz N, Baumruker T, et al. Ovalbumin-induced plasma interleukin-4 levels are reduced in ceramide kinase-deficient DO11.10 RAG1-/- mice. Lipids Health Dis 2010; 9: 1.
9. Idzko M, Hammad H, van Nimwegen M, et al. Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function. J Clin Invest 2006; 116: 2935-2944.
10. Chalfant CE, Spiegel S. Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. J Cell Sci 2005; 118: 4605-4612.
11. Gomez-Munoz A, Kong JY, Salh B, et al. Ceramide-1-phosphate blocks apoptosis through inhibition of acid sphingomyelinase in macrophages. J Lipid Res 2004; 45: 99-105.
12. Granado MH, Gangoiti P, Ouro A, et al. Ceramide 1-phosphate inhibits serine palmitoyltransferase and blocks apoptosis in alveolar macrophages. Biochim Biophys Acta 2009; 1791: 263-272.
13. Levy M, Khan E, Careaga M, et al. Neutral sphingomyelinase 2 is activated by cigarette smoke to augment ceramide-induced apoptosis in lung cell death. Am J Physiol Lung Cell Mol Physiol 2009; 297: L125-L133.
14. Goldsmith M, Avni D, Levy-Rimler G, et al. A ceramide-1-phosphate analogue, PCERA-1, simultaneously suppresses tumour necrosis factor-alpha and induces interleukin-10 production in activated macrophages. Immunology 2009; 127: 103-115.
15. Arana L, Ordonez M, Ouro A, et al. Ceramide 1-phosphate induces macrophage chemoattractant protein-1 release: involvement in ceramide 1-phosphate-stimulated cell migration. Am J Physiol Endocrinol Metab 2013; 304: E1213-E1226.
16. Lucattelli M, Cicko S, Muller T, et al. P2X7 receptor signaling in the pathogenesis of smoke-induced lung inflammation and emphysema. Am J Respir Cell Mol Biol 2011; 44: 423-429.
17. Cicko S, Lucattelli M, Muller T, et al. Purinergic receptor inhibition prevents the development of smoke-induced lung injury and emphysema. J Immunol 2010; 185: 688-697.
18. Libermann TA, Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 1990; 10: 2327-2334.
19. Vlahos R, Bozinovski S, Jones JE, et al. Differential protease, innate immunity, and NF-kappaB induction profiles during lung inflammation induced by subchronic cigarette smoke exposure in mice. Am J Physiol Lung Cell Mol Physiol 2006; 290: L931-L945.
20. Di Stefano A, Caramori G, Oates T, et al. Increased expression of nuclear factor-κB in bronchial biopsies from smokers and patients with COPD. Eur Respir J 2002; 20: 556-563.
21. Teichgraber V, Ulrich M, Endlich N, et al. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat Med 2008; 14: 382-391.
22. Lamour NF, Chalfant CE. Ceramide-1-phosphate: the "missing" link in eicosanoid biosynthesis and inflammation. Mol Interv 2005; 5: 358-367.
23. Matsusaka T, Fujikawa K, Nishio Y, et al. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA 1993; 90: 10193-10197.
24. Nixon GF. Sphingolipids in inflammation: pathological implications and potential therapeutic targets. Br J Pharmacol 2009; 158: 982-993.
25. Fyrst H, Saba JD. An update on sphingosine-1-phosphate and other sphingolipid mediators. Nat Chem Biol 2010; 6: 489-497.
26. Arana L, Gangoiti P, Ouro A, et al. Ceramide and ceramide 1-phosphate in health and disease. Lipids Health Dis 2010; 9: 15.
27. Gomez-Munoz A, Gangoiti P, Arana L, et al. New insights on the role of ceramide 1-phosphate in inflammation. Biochim Biophys Acta 2013; 1831: 1060-1066.
28. Granado MH, Gangoiti P, Ouro A, et al. Ceramide 1-phosphate (C1P) promotes cell migration involvement of a specific C1P receptor. Cell Signal 2009; 21: 405-412.
29. Tauzin L, Graf C, Sun M, et al. Effects of ceramide-1-phosphate on cultured cells: dependence on dodecane in the vehicle. J Lipid Res 2007; 48: 66-76.
30. Bracke KR, Verhamme FM, Seys LJ, et al. Role of CXCL13 in cigarette smoke-induced lymphoid follicle formation and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 188: 343-355.
31. Filosto S, Castillo S, Danielson A, et al. Neutral sphingomyelinase 2: a novel target in cigarette smoke-induced apoptosis and lung injury. Am J Respir Cell Mol Biol 2011; 44: 350-360.
32. Comer DM, Kidney JC, Ennis M, et al. Airway epithelial cell apoptosis and inflammation in COPD, smokers and nonsmokers. Eur Respir J 2013; 41: 1058-1067.
33. Hankins JL, Fox TE, Barth BM, et al. Exogenous ceramide-1-phosphate reduces lipopolysaccharide (LPS)-mediated cytokine expression. J Biol Chem 2011; 286: 44357-44366.
34. Pettus BJ, Bielawska A, Subramanian P, et al. Ceramide 1-phosphate is a direct activator of cytosolic phospholipase A2. J Biol Chem 2004; 279: 11320-11326.
35. Chen BC, Chang HM, Hsu MJ, et al. Peptidoglycan induces Cyclooxygenase-2 expression in macrophages by activating the neutral sphingomyelinase-ceramide pathway. J Biol Chem 2009; 284: 20562-20573.
36. Barnes PJ. New anti-inflammatory targets for chronic obstructive pulmonary disease. Nat Rev Drug Discov 2013; 12: 543-559.
37. Chiba N, Masuda A, Yoshikai Y, et al. Ceramide inhibits LPS-induced production of IL-5, IL-10, and IL-13 from mast cells. J Cell Physiol 2007; 213: 126-136.